Background: Lipocalin-2 (LCN2) is a protein that has been associated with skeletal muscle regeneration, but details regarding its role in Arthritis remain unclear. The aim of the current study was to investigate LCN2 levels of Arthritis patients and its relationship with oxidative and antioxidative factors.Methods: The study includes (125) blood samples of persons aged 20-65 years were divided into a control group (apparently healthy) consisting of 55 samples [31female, 24 males] and a Patient group consisting of 70 samples [37female, 33 males] who were attending the bone diseases consultation unit at the Ibn Sina Teaching Hospital in Mosul, Iraq. Venous blood samples (10 ml) were collected after overnight fasting. To conduct Clinical analyses: Serum LCN2 level was determined by ELISA, also Malonaldehyde, glutathione, vitamin E, vitamin C, peroxy nitrite, peroxidase, and aryl esterase were estimated.Results: The findings revealed a significant increase in the levels of LCN2 in Arthritis compared to the control group and there was a significant decrease in the concentration of vitamin C, glutathione, vitamin E and the activity of the arylesterase in serum of patients with arthritis compared with the control group. Also, a significant increase in the activity of peroxidase, concentration of peroxynitrite and malondialdehyde for patients than a control group.Conclusion: These findings imply that LCN2 may play a substantial role in iron-related oxidative stress damage in arthritis. Thus a therapeutic candidate target for treatment.
Background: Asprosin is correlated to many pathologic of glucose dysregulation, insulin resistance, β-cell dysfunction, serum lipids, and adiposity.Objective investigating the role of the asprosin hormone and its relationship to insulin resistance in newly diagnosed metabolic syndrome and clinical parameters.Methods: The study included measurement of asprosin hormone, insulin, insulin resistance and some biochemical variable levels in metabolic syndrome patients with age matching to the control group (35 - 65 years). The study included the measurement of asprosin hormone. MetS were diagnosed in compliance with the European Group for the Study of Insulin Resistance (EGIR) criteria for patients attending the abdominal consultation unit at the Ibn Sina Teaching Hospital in Mosul, Iraq.Results: The findings revealed a significant increase in the concertation of asprosin hormone in metabolic syndrome patients compared to the control group. Also, it has been found that was a significant increase in the concertation of glucose, insulin, homeostasis model for insulin resistance (HOMA-IR), Glucose to insulin Ratio(G/I), Triglyceride Glucose index (TyG), and McAuley Index, in addition to decreasing in homeostasis model for β-cell function(HOMA-%β), sensitivity of insulin(HOMA-%S) and Quantitative insulin sensitivity check index(QUICKI) in the metabolic syndrome patients. there is also a significant positive correlation between asprosin hormone with insulin resistance.Conclusion: Findings indicated that serum levels of asprosin and insulin resistance are increased in patients with metabolic syndrome. Also, they have a relationship with clinical parameters. So asprosin hormone can be used new biomarker of metabolic turbulence.
- Klíčová slova
- asprosin,
- MeSH
- biologické markery analýza MeSH
- dospělí MeSH
- hormony analýza MeSH
- index tělesné hmotnosti MeSH
- inzulinová rezistence * fyziologie MeSH
- inzuliny analýza MeSH
- klinické laboratorní techniky metody přístrojové vybavení MeSH
- lidé středního věku MeSH
- lidé MeSH
- metabolický syndrom * komplikace patologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- klinická studie MeSH
